Prosight Management, LP - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 38 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q2 2019$3,541,000
-11.0%
815,789
+50.3%
1.78%
+2.5%
Q1 2019$3,980,000
-21.9%
542,919
-19.7%
1.74%
-33.9%
Q4 2018$5,098,000
-32.5%
676,104
-49.4%
2.63%
-37.5%
Q3 2018$7,555,000
+52.6%
1,337,191
+18.8%
4.21%
+16.1%
Q2 2018$4,951,0001,125,1533.63%
Other shareholders

There were no reported owners of INTEC PHARMA LTD JERUSALEM in Q3 2019.

NameSharesValueWeighting ↓
View complete list of INTEC PHARMA LTD JERUSALEM shareholders